# UBIAD1

## Overview
The UBIAD1 gene encodes the UbiA prenyltransferase domain containing 1 protein, a membrane-embedded prenyltransferase involved in the biosynthesis of essential biomolecules such as Coenzyme Q10 (CoQ10) and vitamin K2 (MK-4). This protein is characterized by its nine transmembrane helices and is primarily localized to the mitochondria, where it plays a significant role in cellular metabolism and cholesterol homeostasis (Nickerson2010UBIAD1; Huang2014Structure). UBIAD1's enzymatic activity is crucial for the prenylation process, which is vital for the synthesis of CoQ10, an important antioxidant, and MK-4, a key component in blood coagulation and mitochondrial electron transport (Hirota2015Functional; Mugoni2013Ubiad1). Mutations in the UBIAD1 gene are linked to Schnyder corneal dystrophy, a disorder characterized by cholesterol accumulation in the cornea, highlighting the gene's importance in maintaining lipid balance (Nickerson2010UBIAD1; Jiang2019Schnyder).

## Structure
The UBIAD1 protein is a membrane-embedded prenyltransferase with a structure characterized by nine transmembrane helices, similar to its archaeal homologs (Zhou2020Structural; Huang2014Structure). These helices form a substrate-binding cleft, crucial for its enzymatic function (Nickerson2010UBIAD1). The protein contains two conserved aspartate-rich motifs, which are essential for binding magnesium ions and the prenyl substrate, facilitating the prenyl transfer reaction (Huang2014Structure). 

The active site of UBIAD1 includes residues such as Asn102, which is involved in substrate binding and catalysis (Nickerson2010UBIAD1; Zhou2020Structural). Mutations in this region, such as N102S, are linked to Schnyder corneal dystrophy, affecting substrate docking and enzyme activity (Nickerson2010UBIAD1). The protein's structure is stabilized by the coordination of Mg2+ ions, which are crucial for its activity (Huang2014Structure).

UBIAD1 is localized to the mitochondria, indicating its role in cellular metabolism (Nickerson2010UBIAD1). The protein's structure and function are conserved across species, highlighting its evolutionary significance (Nickerson2010UBIAD1).

## Function
The UBIAD1 gene encodes a prenyltransferase enzyme that plays a crucial role in the biosynthesis of Coenzyme Q10 (CoQ10) and vitamin K2 (MK-4) in healthy human cells. UBIAD1 is primarily active in the Golgi apparatus and endoplasmic reticulum, where it facilitates the prenylation of target molecules, a key step in the synthesis of these compounds (Hirota2015Functional; Mugoni2013Ubiad1).

CoQ10, synthesized by UBIAD1, is a vital antioxidant that protects cells from oxidative stress by balancing reactive oxygen species (ROS) levels. This function is particularly important in cardiovascular tissues, where CoQ10 helps prevent lipid peroxidation and supports endothelial nitric oxide synthase (eNOS) activity, crucial for nitric oxide signaling and cardiovascular health (Mugoni2013Ubiad1).

UBIAD1 also contributes to cholesterol metabolism by interacting with HMG CoA reductase, regulating cholesterol levels and preventing excessive accumulation. This regulation is essential for maintaining cellular lipid homeostasis and preventing diseases associated with cholesterol imbalance (Xie2021Functional).

In addition to its role in CoQ10 synthesis, UBIAD1 is involved in the conversion of vitamin K derivatives to MK-4, which is important for blood coagulation and electron transport in mitochondria (Hirota2015Functional).

## Clinical Significance
Mutations in the UBIAD1 gene are primarily associated with Schnyder corneal dystrophy (SCD), a rare autosomal dominant disorder characterized by cholesterol and lipid accumulation in the cornea, leading to corneal opacification and visual impairment (Nickerson2010UBIAD1; Jiang2019Schnyder). Over 20 mutations in UBIAD1 have been identified in relation to SCD, including common mutations such as N102S and novel mutations like A97T, V122E, and L188H (Lin2016Identification; Nickerson2010UBIAD1). These mutations often occur in highly conserved regions of the gene, affecting the protein's prenyltransferase activity, which is crucial for its function in cholesterol metabolism (Weiss2007Mutations; Jiang2019Schnyder).

The mutations in UBIAD1 disrupt its normal localization and function, leading to impaired cholesterol homeostasis. For instance, SCD-associated mutations cause UBIAD1 to mislocalize to the endoplasmic reticulum instead of the Golgi apparatus, preventing the degradation of HMG-CoA reductase and resulting in cholesterol accumulation in the cornea (Jiang2019Schnyder). This mislocalization and subsequent cholesterol buildup are key factors in the pathogenesis of SCD (Jiang2019Schnyder). Understanding these genetic mutations is crucial for developing targeted therapies for SCD (Nickerson2010UBIAD1).

## Interactions
UBIAD1 interacts with several proteins, influencing various cellular processes. It binds to the C-terminal domain of H-Ras, inhibiting its trafficking from the Golgi apparatus to the plasma membrane. This interaction prevents the activation of the Ras/MAPK signaling pathway, which is crucial for cell proliferation and signaling in bladder carcinoma cells (Xu2018UBIAD1). UBIAD1's interaction with H-Ras is supported by fluorescence resonance energy transfer (FRET) assays and coimmunoprecipitation experiments, which demonstrate a strong interaction, particularly with the H-Ras G12V mutant (Xu2018UBIAD1).

UBIAD1 also interacts with HMG-CoA reductase (HMGCR), a key enzyme in cholesterol biosynthesis. In the context of Schnyder corneal dystrophy (SCD), mutations in UBIAD1, such as G186R, enhance its binding to HMGCR, preventing its degradation. This interaction leads to increased cholesterol synthesis and accumulation (Jiang2019Schnyder). The interaction between UBIAD1 and HMGCR is crucial for regulating cholesterol homeostasis, as UBIAD1 competes with Insig proteins for binding to HMGCR, affecting its ubiquitination and degradation (Jiang2019Schnyder).

UBIAD1 also interacts with APOE, a cholesterol carrier protein. This interaction is implicated in cholesterol modulation and tumor progression, with certain mutations in UBIAD1 reducing its binding to APOE, potentially contributing to elevated cholesterol levels (Fredericks2011The).


## References


[1. (Fredericks2011The) William J. Fredericks, Terry McGarvey, Huiyi Wang, Priti Lal, Raghunath Puthiyaveettil, John Tomaszewski, Jorge Sepulveda, Ed Labelle, Jayne S. Weiss, Michael L. Nickerson, Howard S. Kruth, Wolfgang Brandt, Ludger A. Wessjohann, and S. Bruce Malkowicz. The bladder tumor suppressor protein tere1 (ubiad1)modulates cell cholesterol: implications for tumor progression. DNA and Cell Biology, 30(11):851–864, November 2011. URL: http://dx.doi.org/10.1089/dna.2011.1315, doi:10.1089/dna.2011.1315. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/dna.2011.1315)

2. (Zhou2020Structural) Structural basis for the HMGCR interaction with UBIAD1 mutants causing Schnyder corneal dystrophy. This article has 0 citations.

[3. (Lin2016Identification) Benjamin R. Lin, Ricardo F. Frausto, Rosalind C. Vo, Stephan Y. Chiu, Judy L. Chen, and Anthony J. Aldave. Identification of the firstde novo ubiad1gene mutation associated with schnyder corneal dystrophy. Journal of Ophthalmology, 2016:1–9, 2016. URL: http://dx.doi.org/10.1155/2016/1968493, doi:10.1155/2016/1968493. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2016/1968493)

[4. (Xu2018UBIAD1) Zhiliang Xu, Fengsen Duan, Huiai Lu, Maytham Abdulkadhim Dragh, Yanzhi Xia, Huageng Liang, and Ling Hong. Ubiad1 suppresses the proliferation of bladder carcinoma cells by regulating h-ras intracellular trafficking via interaction with the c-terminal domain of h-ras. Cell Death &amp; Disease, December 2018. URL: http://dx.doi.org/10.1038/s41419-018-1215-4, doi:10.1038/s41419-018-1215-4. This article has 11 citations.](https://doi.org/10.1038/s41419-018-1215-4)

[5. (Weiss2007Mutations) Jayne S. Weiss, Howard S. Kruth, Helena Kuivaniemi, Gerard Tromp, Peter S. White, R. Scott Winters, Walter Lisch, Wolfram Henn, Elke Denninger, Matthias Krause, Paul Wasson, Neil Ebenezer, Sunil Mahurkar, and Michael L. Nickerson. Mutations in theubiad1gene on chromosome short arm 1, region 36, cause schnyder crystalline corneal dystrophy. Investigative Opthalmology &amp; Visual Science, 48(11):5007, November 2007. URL: http://dx.doi.org/10.1167/iovs.07-0845, doi:10.1167/iovs.07-0845. This article has 82 citations.](https://doi.org/10.1167/iovs.07-0845)

[6. (Hirota2015Functional) Yoshihisa Hirota, Kimie Nakagawa, Natsumi Sawada, Naoko Okuda, Yoshitomo Suhara, Yuri Uchino, Takashi Kimoto, Nobuaki Funahashi, Maya Kamao, Naoko Tsugawa, and Toshio Okano. Functional characterization of the vitamin k2 biosynthetic enzyme ubiad1. PLOS ONE, 10(4):e0125737, April 2015. URL: http://dx.doi.org/10.1371/journal.pone.0125737, doi:10.1371/journal.pone.0125737. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0125737)

[7. (Nickerson2010UBIAD1) Michael L. Nickerson, Brittany N. Kostiha, Wolfgang Brandt, William Fredericks, Ke-Ping Xu, Fu-Shin Yu, Bert Gold, James Chodosh, Marc Goldberg, Da Wen Lu, Masakazu Yamada, Timo M. Tervo, Richard Grutzmacher, Chris Croasdale, Maria Hoeltzenbein, John Sutphin, S. Bruce Malkowicz, Ludger Wessjohann, Howard S. Kruth, Michael Dean, and Jayne S. Weiss. Ubiad1 mutation alters a mitochondrial prenyltransferase to cause schnyder corneal dystrophy. PLoS ONE, 5(5):e10760, May 2010. URL: http://dx.doi.org/10.1371/journal.pone.0010760, doi:10.1371/journal.pone.0010760. This article has 53 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0010760)

[8. (Huang2014Structure) Hua Huang, Elena J. Levin, Shian Liu, Yonghong Bai, Steve W. Lockless, and Ming Zhou. Structure of a membrane-embedded prenyltransferase homologous to ubiad1. PLoS Biology, 12(7):e1001911, July 2014. URL: http://dx.doi.org/10.1371/journal.pbio.1001911, doi:10.1371/journal.pbio.1001911. This article has 95 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.1001911)

[9. (Xie2021Functional) Jumin Xie and Lingxing Li. Functional study of sccd pathogenic gene ubiad1 (review). Molecular Medicine Reports, August 2021. URL: http://dx.doi.org/10.3892/mmr.2021.12345, doi:10.3892/mmr.2021.12345. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2021.12345)

[10. (Mugoni2013Ubiad1) Vera Mugoni, Ruben Postel, Valeria Catanzaro, Elisa De Luca, Emilia Turco, Giuseppe Digilio, Lorenzo Silengo, Michael P. Murphy, Claudio Medana, Didier Y.R. Stainier, Jeroen Bakkers, and Massimo M. Santoro. Ubiad1 is an antioxidant enzyme that regulates enos activity by coq10 synthesis. Cell, 152(3):504–518, January 2013. URL: http://dx.doi.org/10.1016/j.cell.2013.01.013, doi:10.1016/j.cell.2013.01.013. This article has 167 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2013.01.013)

[11. (Jiang2019Schnyder) Shi-You Jiang, Jing-Jie Tang, Xu Xiao, Wei Qi, Suqian Wu, Chao Jiang, Jiaxu Hong, Jianjiang Xu, Bao-Liang Song, and Jie Luo. Schnyder corneal dystrophy-associated ubiad1 mutations cause corneal cholesterol accumulation by stabilizing hmg-coa reductase. PLOS Genetics, 15(7):e1008289, July 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1008289, doi:10.1371/journal.pgen.1008289. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1008289)